Geode Capital Management, LLC Aim Immuno Tech Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 401,027 shares of AIM stock, worth $100,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
401,027
Previous 351,657
14.04%
Holding current value
$100,256
Previous $165,000
10.3%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AIM
# of Institutions
37Shares Held
8.42MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.08MShares$1.02 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$497,1760.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$174,5660.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny229KShares$57,2020.0% of portfolio
-
State Street Corp Boston, MA173KShares$43,2750.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $12M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...